Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H28O4 |
| Molecular Weight | 332.4339 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1=C(O)C(O)=C2C(CC[C@H]3C(C)(C)CCC[C@]23C(O)=O)=C1
InChI
InChIKey=QRYRORQUOLYVBU-VBKZILBWSA-N
InChI=1S/C20H28O4/c1-11(2)13-10-12-6-7-14-19(3,4)8-5-9-20(14,18(23)24)15(12)17(22)16(13)21/h10-11,14,21-22H,5-9H2,1-4H3,(H,23,24)/t14-,20+/m0/s1
| Molecular Formula | C20H28O4 |
| Molecular Weight | 332.4339 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/28918123 | https://www.ncbi.nlm.nih.gov/pubmed/28916593 | https://www.ncbi.nlm.nih.gov/pubmed/28887507 | https://www.ncbi.nlm.nih.gov/pubmed/18848780 | https://www.ncbi.nlm.nih.gov/pubmed/22531045
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/28918123 | https://www.ncbi.nlm.nih.gov/pubmed/28916593 | https://www.ncbi.nlm.nih.gov/pubmed/28887507 | https://www.ncbi.nlm.nih.gov/pubmed/18848780 | https://www.ncbi.nlm.nih.gov/pubmed/22531045
Carnosic acid [CA, (4aR,10aS)-5,6-dihydroxy-1,1-dimethyl-7- propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-4a-carboxylic acid] is a phenolic diterpene found in the leaves of the rosemary plant (Rosmarinus officinalis) and is used routinely as a food and cosmetic additive due to its antioxidant and antimicrobial properties. Carnosic acid as a food additive has a good safety profile and does not pose a health concern. Carnosic acid has demonstrated anti-inflammatory, anticancer, photoprotective, and antiadipogenic activities in vitro. Carnosic acid was shown to induce significant weight loss and reduced visceral adiposity in ob/ob mice fed a diet supplemented with carnosic acid. Carnosic acid is used as a preservative or antioxidant in food and nonfood products (e.g. toothpaste, mouthwash and chewing gum) -in which it has an antimicrobial effect on the microbes responsible for bad breath- or in skin care products.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL340 |
4.3 µM [Ki] | ||
Target ID: CHEMBL1812 |
36.0 µM [IC50] | ||
Target ID: CHEMBL3397 |
9.2 µM [Ki] | ||
Target ID: CHEMBL2366517 |
0.24 µM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Role for the PI3K/Akt/Nrf2 signaling pathway in the protective effects of carnosic acid against methylglyoxal-induced neurotoxicity in SH-SY5Y neuroblastoma cells. | 2015-12-05 |
|
| Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction. | 2015-01-05 |
|
| Induction of Pi form of glutathione S-transferase by carnosic acid is mediated through PI3K/Akt/NF-κB pathway and protects against neurotoxicity. | 2014-11-17 |
|
| Sirtuin 1-mediated inhibition of p66shc expression alleviates liver ischemia/reperfusion injury. | 2014-05 |
|
| Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells. | 2013-10 |
|
| Synergism between carnosic acid and arsenic trioxide on induction of acute myeloid leukemia cell apoptosis is associated with modulation of PTEN/Akt signaling pathway. | 2012-12 |
|
| Anti-inflammatory effects of supercritical carbon dioxide extract and its isolated carnosic acid from Rosmarinus officinalis leaves. | 2011-04-27 |
|
| Carnosic acid: a potent chemopreventive agent against oral carcinogenesis. | 2010-12-05 |
|
| Activation of the nuclear receptor PPARγ by metabolites isolated from sage (Salvia officinalis L.). | 2010-10-28 |
|
| Novel screening method for potential skin-whitening compounds by a luciferase reporter assay. | 2010 |
|
| Carnosic acid protects neuronal HT22 Cells through activation of the antioxidant-responsive element in free carboxylic acid- and catechol hydroxyl moieties-dependent manners. | 2008-04-04 |
|
| Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents. | 2001-08-15 |
Patents
Sample Use Guides
Rats were treated with Injection of 3 mg/kg Carnosic acid daily for 12 days
Route of Administration:
Intraperitoneal
The MIC of Carnosic acid was determined against S. aureus 1199 and S. aureus 1199B in Muller–Hinton Broth in the presence of increasing amounts of efflux pump inhibitors by broth checkerboard synergy method in a microtitre plates using twofold serial dilutions. Each candidate EPI was tested at seven concentrations (100–1.56 mkg/mL). The plates were incubated for 18 h at 37 C and the wells were assessed visually for growth. The minimal effective concentration (MEC) was determined to be the minimal
concentration of EPI that produced the maximal reduction in substrate MIC.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:56:44 GMT 2025
by
admin
on
Mon Mar 31 19:56:44 GMT 2025
|
| Record UNII |
LI791SXT24
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
672 (Number of products:2)
Created by
admin on Mon Mar 31 19:56:44 GMT 2025 , Edited by admin on Mon Mar 31 19:56:44 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
LI791SXT24
Created by
admin on Mon Mar 31 19:56:44 GMT 2025 , Edited by admin on Mon Mar 31 19:56:44 GMT 2025
|
PRIMARY | |||
|
1096746
Created by
admin on Mon Mar 31 19:56:44 GMT 2025 , Edited by admin on Mon Mar 31 19:56:44 GMT 2025
|
PRIMARY | |||
|
m3120
Created by
admin on Mon Mar 31 19:56:44 GMT 2025 , Edited by admin on Mon Mar 31 19:56:44 GMT 2025
|
PRIMARY | Merck Index | ||
|
C018381
Created by
admin on Mon Mar 31 19:56:44 GMT 2025 , Edited by admin on Mon Mar 31 19:56:44 GMT 2025
|
PRIMARY | |||
|
300000054699
Created by
admin on Mon Mar 31 19:56:44 GMT 2025 , Edited by admin on Mon Mar 31 19:56:44 GMT 2025
|
PRIMARY | |||
|
CARNOSIC ACID
Created by
admin on Mon Mar 31 19:56:44 GMT 2025 , Edited by admin on Mon Mar 31 19:56:44 GMT 2025
|
PRIMARY | |||
|
65126
Created by
admin on Mon Mar 31 19:56:44 GMT 2025 , Edited by admin on Mon Mar 31 19:56:44 GMT 2025
|
PRIMARY | |||
|
65585
Created by
admin on Mon Mar 31 19:56:44 GMT 2025 , Edited by admin on Mon Mar 31 19:56:44 GMT 2025
|
PRIMARY | |||
|
DTXSID20904450
Created by
admin on Mon Mar 31 19:56:44 GMT 2025 , Edited by admin on Mon Mar 31 19:56:44 GMT 2025
|
PRIMARY | |||
|
3650-09-7
Created by
admin on Mon Mar 31 19:56:44 GMT 2025 , Edited by admin on Mon Mar 31 19:56:44 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
